Literature DB >> 7625788

Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution models.

S Keil1, B Wiedemann.   

Abstract

In vitro dilution models are used to simulate in vivo drug concentration-time profiles and thus to study the effects of various antibiotic concentrations on the bacteria investigated. The major disadvantage of these models is permanent dilution of the bacterial culture, which falsifies the resulting kill curves. Known equations, which usually correct bacterial loss by simple first-order kinetics, do not take into account special test conditions, such as variable elimination rate constants, exceptionally long periods of investigation, or formation of biofilms. In the present investigation, we examined the validity of these equations with regard to the test conditions mentioned. We simulated the concentration-time curves resulting from continuous infusion of 1,000 mg of meropenem with steady-state levels of 2.5, 5.0, and 7.5 micrograms/ml in an in vitro dilution model. The resulting kill curves were compared with the kill curves obtained from incubation of bacteria in an undiluted system with meropenem at constant concentrations corresponding to the above-mentioned steady-state levels. Comparison of the matching kill curves showed that the common corrections, which do not consider the formation of biofilms in the compartments, partly overestimated the effect of bacterial dilution. We defined a factor, f, as an extension to the known equations which compensates for the effect of biofilms. Another extension was developed to allow the investigation of variable elimination rate constants. With the help of these extended mathematical corrections, we were able to fit the kill curves resulting from the in vitro dilution model exactly to the kill curves given by an undiluted system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625788      PMCID: PMC162682          DOI: 10.1128/AAC.39.5.1054

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Artifacts in dilution pharmacokinetic models caused by adherent bacteria.

Authors:  R Haag; P Lexa; I Werkhäuser
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

2.  Bactericidal activity of meropenem against Pseudomonas aeruginosa.

Authors:  E Yourassowsky; M P Van der Linden; M J Lismont; F Crokaert; Y Glupczynski
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

3.  In vitro model simulating the form of exposure of bacteria to antimicrobial drugs encountered in infection.

Authors:  M J Al-Asadi; D Greenwood; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

4.  Correction for bacterial loss in in vitro dilution models.

Authors:  C A White; R D Toothaker; A L Smith; J T Slattery
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

5.  Bactericidal activity of two different dosage regimens of imipenem in an in-vitro dynamic model.

Authors:  F Maggiolo; A Taras; S Frontespezi; F Bottari; M C Legnani; F Suter
Journal:  J Antimicrob Chemother       Date:  1993-08       Impact factor: 5.790

6.  Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia.

Authors:  Y Saino; F Kobayashi; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

7.  New in vitro kinetic model for evaluating bactericidal efficacy of antibiotics.

Authors:  T Murakawa; H Sakamoto; T Hirose; M Nishida
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

8.  Comparison of high performance liquid chromatography and microbiological assay in the determination of plasma cefuroxime concentrations in rabbits.

Authors:  Y A Hekster; A M Baars; T B Vree; B van Klingeren; A Rutgers
Journal:  J Antimicrob Chemother       Date:  1980-01       Impact factor: 5.790

9.  New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity.

Authors:  S Grasso; G Meinardi; I de Carneri; V Tamassia
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

10.  Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model.

Authors:  J Blaser; B B Stone; S H Zinner
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

  10 in total
  11 in total

Review 1.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.

Authors:  Markus Mueller; Amparo de la Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

2.  Relationships between antimicrobial effect and area under the concentration-time curve as a basis for comparison of modes of antibiotic administration: meropenem bolus injections versus continuous infusions.

Authors:  A A Firsov; H Mattie
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

3.  Pharmacodynamics of moxifloxacin against anaerobes studied in an in vitro pharmacokinetic model.

Authors:  Alan R Noel; Karen E Bowker; Alasdair P Macgowan
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model.

Authors:  S Keil; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

Review 5.  In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB.

Authors:  Pavan K Vaddady; Richard E Lee; Bernd Meibohm
Journal:  Future Med Chem       Date:  2010-08       Impact factor: 3.808

6.  Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection.

Authors:  R E Lewis; M E Klepser; E J Ernst; B C Lund; D J Biedenbach; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

7.  Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditis.

Authors:  R C Mercier; M J Rybak; A S Bayer; M R Yeaman
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

8.  Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.

Authors:  M E Klepser; E J Ernst; C R Petzold; P Rhomberg; G V Doern
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

9.  Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa.

Authors:  Jürgen B Bulitta; Neang S Ly; Jenny C Yang; Alan Forrest; William J Jusko; Brian T Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

10.  Development of resistance in wild-type and hypermutable Pseudomonas aeruginosa strains exposed to clinical pharmacokinetic profiles of meropenem and ceftazidime simulated in vitro.

Authors:  Beate Henrichfreise; Irith Wiegand; Ingeborg Luhmer-Becker; Bernd Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.